Search results
Terns (TERN) Gains 13.6% YTD: Will the Momentum Continue?
Zacks· 2 days agoTerns Pharmaceuticals, Inc. (TERN) outperforms the industry year to date on encouraging pipeline progress of its oncology candidate.
Lilly and subsidiary Point Biopharma accused of patent infringement of cancer drugs - Indianapolis...
Indianapolis Business Journal· 4 days agoThe research foundation filed a complaint in U.S. District Court on Thursday. Companies Endocyte...
Pharma giant's data breach exposes patients' sensitive information
Fox News via Yahoo News· 4 days agoPharmaceutical giant Cencora has notified people that private medical information, including health...
Radiopharma specialist Telix pulls last-minute plug on $232m IPO
Pharmaceutical Technology via Yahoo Finance· 4 days agoGlobalData is the parent company of Pharmaceutical Technology. Big pharma has made plays for the...
Ionis (IONS) Expands Licensing Deal With Otsuka for HAE Drug
Zacks via Yahoo Finance· 2 days agoIonis (IONS) out-licenses the rights for its HAE drug to Otsuka in the Asia-Pacific region. The...
Psoriatic Arthritis Drugs Comparably Improve Joint Outcomes
Medscape· 2 days agoReal-world study data suggest there is little difference among five drug classes commonly used to...
Investing in the heart of Central Europe - Foreign Policy
Foreign Policy Magazine· 5 days agoSituated in the heart of Europe, Hungary represents a beacon of economic resilience and investment...
APAC leaps ahead in adoptive cell therapy space
Pharmaceutical Technology via Yahoo Finance· 4 days agoGlobalData is the parent company of Pharmaceutical Technology. Adoptive cell therapies are immunotherapies that use engineered cells to trigger a...
Ranking the top ten clinical research organisations in the world
Pharmaceutical Technology via Yahoo Finance· 3 days agoClinical research organisations assist drug manufacturers during the clinical trial process to...
Biotech startup raises $190 million to focus on new approach to heart attack, stroke and more - San...
The Business Journals· 3 days agoA serial biotech entrepreneur, a longtime UCSF researcher, a shelved Big Pharma drug and $190...
